An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

February 28, 2019

Conditions
Osteoarthritis
Interventions
PROCEDURE

Knee injection

Injection into knee for the treatment of Osteoarthritis

OTHER

ReNu amniotic allograft

DEVICE

placebo saline

DEVICE

Hyaluronic Acid

Trial Locations (12)

10003

New York University, New York

10021

Hospital for Special Surgery, New York

23294

Advanced Orthopedics, Richmond

35205

American Sports Medicine Institute, Birmingham

43221

The Ohio State University, Columbus

46143

Orthoindy, Indianapolis

60612

Midwest Orthopedics at Rush, LLC, Chicago

65212

Missouri Orthopaedic Institute (MOI), Columbia

87106

New Mexico Orthopaedics, Albuquerque

90048

Cedars-Sinai Medical Center, Los Angeles

40536-2093

Center for Clinical and Translational Science UK Chandler Medical Center, Pavilion H, Lexington

02467

Brigham and Women's Hospital, Chestnut Hill

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Organogenesis

INDUSTRY

lead

NuTech Medical, Inc

INDUSTRY

NCT02318511 - An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis | Biotech Hunter | Biotech Hunter